Neuroprotection in stroke: past, present, and future. 2014

Arshad Majid
Department of Neuroscience, Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385A Glossop Road, Sheffield S10 2HQ, UK ; Department of Neurology and Manchester Academic Health Sciences Centre, Salford Royal Hospital, Stott Lane, Salford M6 8HD, UK.

Stroke is a devastating medical condition, killing millions of people each year and causing serious injury to many more. Despite advances in treatment, there is still little that can be done to prevent stroke-related brain damage. The concept of neuroprotection is a source of considerable interest in the search for novel therapies that have the potential to preserve brain tissue and improve overall outcome. Key points of intervention have been identified in many of the processes that are the source of damage to the brain after stroke, and numerous treatment strategies designed to exploit them have been developed. In this review, potential targets of neuroprotection in stroke are discussed, as well as the various treatments that have been targeted against them. In addition, a summary of recent progress in clinical trials of neuroprotective agents in stroke is provided.

UI MeSH Term Description Entries

Related Publications

Arshad Majid
September 2008, Neuropharmacology,
Arshad Majid
January 2010, Casopis lekaru ceskych,
Arshad Majid
January 2009, Advances in pediatrics,
Arshad Majid
January 2018, Brain and neuroscience advances,
Arshad Majid
November 2010, Rinsho shinkeigaku = Clinical neurology,
Arshad Majid
November 2006, International journal of stroke : official journal of the International Stroke Society,
Arshad Majid
January 2008, European neurology,
Arshad Majid
October 2006, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!